Phase i trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

Loren Michel, Jessica Ley, Tanya M. Wildes, András Schaffer, Anthony Robinson, Se Eun Chun, Wooin Lee, James Lewis, Kathryn Trinkaus, Douglas Adkins

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Fingerprint

Dive into the research topics of 'Phase i trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences